Genoa Ventures
- Company typePrivate
- Founded2018
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
Genoa Ventures firmographics
Firmographics- Name
- Genoa Ventures
- Legal name
- Genoa Ventures
- Website
- https://genoavc.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Genoa Ventures industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investment Advice (6282), Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
- akta.pro secondary industries
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD), Late-Stage Venture Capital (Series C+) (FSANAAAC)
Keywords
Where Genoa Ventures is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Genoa Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Venture Capital Fund Management: Genoa Ventures generates returns through management fees on funds under management and carried interest (performance fees) on successful portfolio exits. The firm manages over $150 million in assets across multiple funds, with returns realized through portfolio company exits via acquisitions and IPOs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Genoa Ventures product offering
Product offeringCore offering
Genoa Ventures is a venture capital firm that deploys capital into early-stage life sciences companies at the convergence of biology and technology. The firm invests primarily at the seed and Series A stages, typically leading or co-leading rounds, and provides hands-on support including deal diligence and strategic guidance to portfolio companies. The firm manages over $150 million in assets across multiple funds and focuses on research tools, diagnostics, agriculture, animal health, bio-manufacturing, biodefense, industrial biology, synthetic biology, and genetic engineering.
Product overview
Genoa Ventures is a venture capital firm offering a single unified investment service rather than a platform-plus-modules architecture. The firm deploys capital and expertise to science-driven companies working at the intersection of biology and technology, with a focus on early-stage investments (typically seed or Series A). The firm manages over $150 million across three funds and invests across areas including research tools, diagnostics, agriculture, animal health, bio manufacturing, biodefense, industrial bio, synthetic biology, and genetic engineering. As a VC firm, Genoa does not offer discrete software products or modules but rather provides investment capital, strategic guidance, and operational support to portfolio companies.
Differentiator
Problem solved
Functional benefit
Products and services
- Genoa Ventures Investment Services
Quantifiable outcome
- Five FDA clearances across portfolio companies in 2025
- +2 more outcomes
Companies that use Genoa Ventures
Customer profileNamed customers9 records
Segments2 records
Ideal customer profiles2 records
Genoa Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Genoa Ventures partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Hawkwood Biotech PartnerscoreHawkwood Bio is the world's premier consultancy supporting industrial and food biotech companies with engineering, manufacturing, strategy, business development and fundraising services. Hawkwood founders Tony Day and Richard Kenny serve as Venture Partners at Genoa. The broader Hawkwood team actively sources and diligence investment opportunities in Industrial Bio and AgriFood, and provides deep industry expertise to Genoa portfolio companies.
- General InceptioncoreGeneral Inception is pioneering company creation as the first Igniter company, bringing a new way to partner with scientific inventors to ignite innovation and nurture transformational companies. As a Member Venture Capital company in General Inception, Genoa enjoys early access to new companies founded by General Inception. Partner Vikram Chaudhery is a Founder of General Inception, creating additional synergies.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Genoa Ventures competitors and assessment
Company assessmentDirect peers
- Lux Capital: Early-stage venture firm investing at the intersection of science and technology, including life sciences, deep tech, and frontier computing. Comparable in stage, sector focus, and founder-friendly operating style.
- Section 32: Venture fund investing in early-stage life sciences, biotech, and healthcare companies. Direct competitor for seed and Series A life sciences deals with similar scientific thesis-driven approach.
- Atlas Venture: Early-stage life sciences venture firm that builds and invests in biotech startups. Directly comparable stage and sector focus, with a similar hands-on company-creation model.
- 5AM Ventures: Early-stage venture capital firm focused on life sciences, including biotech, pharmaceuticals, and medical devices. Comparable fund size and seed/Series A focus in life sciences.
- Civilization Ventures: Early-stage venture firm investing at the intersection of technology and biology, with a focus on synthetic biology and biotech. Very comparable in thesis, stage, and target founders.
- Prime Movers Lab: Early-stage venture firm backing breakthrough scientific discoveries in life sciences, energy, and computing. Comparable seed/Series A focus on deep science and category-defining companies.
- Versant Ventures: Healthcare-focused venture firm investing across biotech, medical devices, and diagnostics at early stages. Directly comparable in life sciences focus and early-stage deal activity.
Broad incumbents
- ARCH Venture Partners: One of the largest early-stage life sciences and technology venture firms, with a much broader portfolio and larger fund sizes. Competes for similar seed/Series A deals in biotech and genomics.
- Andreessen Horowitz (Bio/Health Fund): Large multi-stage venture firm with a dedicated bio/health fund investing across life sciences. Competes for similar deals but with substantially larger fund size and broader portfolio.
- Khosla Ventures: Early-stage venture firm investing across technology and science, with significant life sciences exposure. Comparable in stage and founder-friendly approach, though much larger and more diversified.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Genoa Ventures social profiles
Digital presenceGenoa Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genoa Ventures leadership team
Management profileNumber of profiles
Profiles11 records
Genoa Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genoa Ventures M&A and investment
M&A and investmentM&A
Investments40 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genoa Ventures
What does Genoa Ventures do?
Genoa Ventures is a venture capital firm that deploys capital into early-stage life sciences companies at the convergence of biology and technology. The firm invests primarily at the seed and Series A stages, typically leading or co-leading rounds, and provides hands-on support including deal diligence and strategic guidance to portfolio companies. The firm manages over $150 million in assets across multiple funds and focuses on research tools, diagnostics, agriculture, animal health, bio-manufacturing, biodefense, industrial biology, synthetic biology, and genetic engineering.
Is Genoa Ventures a public or private company?
Genoa Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Genoa Ventures founded?
Genoa Ventures was founded in 2018. It employs 1 to 10 people.
Where is Genoa Ventures based?
Genoa Ventures is headquartered in San Francisco, United States, in the North America region.
How does Genoa Ventures make money?
One revenue line is on record: venture Capital Fund Management.
Who are Genoa Ventures's main competitors?
Direct peers on record are Lux Capital, Section 32, Atlas Venture, 5AM Ventures, Civilization Ventures, Prime Movers Lab and Versant Ventures. Broad incumbents are ARCH Venture Partners, Andreessen Horowitz (Bio/Health Fund) and Khosla Ventures.
Does Genoa Ventures have an API?
No public API is recorded for Genoa Ventures.
What industry is Genoa Ventures in?
Genoa Ventures's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.